Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

DaVita HealthCare Partners ( DVA) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.6%. By the end of trading, DaVita HealthCare Partners fell $0.76 (-1.1%) to $66.07 on average volume. Throughout the day, 1,547,336 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1,959,700 shares. The stock ranged in price between $65.84-$67.00 after having opened the day at $66.73 as compared to the previous trading day's close of $66.83. Other companies within the Health Services industry that declined today were: NeoGenomics ( NEO), down 15.3%, Escalon Medical Corporation ( ESMC), down 10.3%, Alphatec Holdings ( ATEC), down 9.1% and CombiMatrix Corporation ( CBMX), down 7.8%.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $14.1 billion and is part of the health care sector. Shares are up 4.7% year to date as of the close of trading on Tuesday. Currently there are 9 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, growth in earnings per share, compelling growth in net income, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows low profit margins.

On the positive front, Dehaier Medical Systems ( DHRM), up 34.6%, Oculus Innovative ( OCLS), up 20.6%, IsoRay ( ISR), up 11.6% and Concord Medical Services Holdings ( CCM), up 11.3%.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.